Back to Dashboard
Unknown

Novocure Ltd

USA Unknown Filing: 2026-03-31
29/100
Smart-money confidence1 of 3 sources positive
Weak — few signals

No standout activity across the feeds we track.

Hedge funds
38
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Who's behind the signal
Every informed buyer we can see on NOVOCURE LTD, across all three feeds.
Hedge funds · 7
Point72 (Steve Cohen) Increased +51%
Baillie Gifford & Co Decreased −4%
Tudor Investment (Paul Tudor Jones) Decreased −22%
D.E. Shaw & Co Decreased −21%
Citadel Advisors Decreased −87%
AQR Capital Management Decreased −34%
+1 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Not a model pick — but on our radar. NOVOCURE LTD isn't in the top-10 model right now, but 7 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
7
Investors
0
New positions
1
Increasing
6
Decreasing
0
Unchanged
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Point72 (Steve Cohen)
Trust weight: 1.1×
Increased +51%
% of portfolio
0.0%
Position change
+51%
0.0% of Point72's portfolio
Baillie Gifford & Co
Trust weight: 1.4×
Decreased −4%
% of portfolio
0.0%
Position change
−4%
0.0% of Baillie Gifford & Co's portfolio
Tudor Investment (Paul Tudor Jones)
Trust weight: 1.2×
Decreased −22%
% of portfolio
0.0%
Position change
−22%
0.0% of Tudor Investment's portfolio
D.E. Shaw & Co
Trust weight: 1.0×
Decreased −21%
% of portfolio
0.0%
Position change
−21%
0.0% of D.E. Shaw & Co's portfolio
Citadel Advisors
Trust weight: 1.0×
Decreased −87%
% of portfolio
0.0%
Position change
−87%
0.0% of Citadel Advisors's portfolio
AQR Capital Management
Trust weight: 1.0×
Decreased −34%
% of portfolio
0.0%
Position change
−34%
0.0% of AQR Capital Management's portfolio
Millennium Management (Englander)
Trust weight: 1.0×
Decreased −86%
% of portfolio
0.0%
Position change
−86%
0.0% of Millennium Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to NOVOCURE LTD
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell NOVOCURE LTD or any security.

订阅每周更新

我们每周会把巴菲特、达利欧、阿克曼以及另外 47 位传奇投资人正在买入的股票发送给你 — 免费，直接来自他们的 SEC 申报文件。
永久免费 · 无垃圾邮件 · 随时退订
© 2026 Bogen Capital  ·  Not financial advice  ·  Data delayed up to 135 days Methodology  ·  Contact  ·  API